Sumati Rao
No ORCID on file
· 1 paper in corpus
· active 2024
Study types
- article 1
Frequent coauthors
article
2024
Fewer transfusions with momelotinib are projected to result in cost and time savings in patients with myelofibrosis and anemia compared with danazol.